Semi-Annual Statement Of Income And Retained Earnings

Fuso Pharmaceutical Industries,Ltd. - Filing #7329099

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
1,964,000,000 JPY
2,206,000,000 JPY
Non-operating income
Non-operating income
232,000,000 JPY
390,000,000 JPY
Non-operating expenses
Non-operating expenses
328,000,000 JPY
380,000,000 JPY
Ordinary profit (loss)
1,868,000,000 JPY
2,215,000,000 JPY
Extraordinary income
Extraordinary income
39,000,000 JPY
JPY
Extraordinary losses
Extraordinary losses
140,000,000 JPY
10,000,000 JPY
Profit (loss) before income taxes
1,767,000,000 JPY
2,205,000,000 JPY
Income taxes - current
425,000,000 JPY
519,000,000 JPY
Income taxes - deferred
-35,000,000 JPY
80,000,000 JPY
Profit (loss)
1,377,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
1,605,000,000 JPY
1,605,000,000 JPY
1,605,000,000 JPY
1,605,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.